PMID- 36001730 OWN - NLM STAT- MEDLINE DCOM- 20221026 LR - 20230825 IS - 1365-2249 (Electronic) IS - 0009-9104 (Print) IS - 0009-9104 (Linking) VI - 210 IP - 1 DP - 2022 Oct 21 TI - Upregulated expression of substance P and NK1R in blood monocytes and B cells of patients with allergic rhinitis and asthma. PG - 39-52 LID - 10.1093/cei/uxac074 [doi] AB - Increased expression of substance P (SP) and neurokinin-1 receptor (NK1R) has been noticed in patients with allergic rhinitis (AR) and allergic asthma (AA). However, little is known of the expression of SP and NK1R in monocytes and B cells of AR and AA. In the present study, the expression levels of SP and NK1R were determined by flow cytometry and mouse AR and AA models. The results showed that both percentages of SP+ monocytes and SP+ B cells, and mean fluorescence intensity (MFI) of SP in monocytes were elevated in the blood of AA and AR combined with AA (ARA) patients. Similarly, the percentages of NK1R+ monocytes were elevated in the blood of AR, AA, and ARA patients. Allergens Artemisia sieversiana wild allergen extract (ASWE), house dust mite extract (HDME), and Platanus pollen allergen extract (PPE) increased the expression density of SP molecules (determined by MFI) in an individual monocyte of AR patients. HDME and PPE appeared to enhance SP and NK1R expression in the B cells of ARA and AR patients. In the mouse AR and AA models, the percentages of NK1R+ monocytes and B cells were elevated in blood following OVA (ovalbumin) sensitization and challenge. Knocking out the FcepsilonRI molecule completely abolished the OVA-induced upregulation of expression of NK1R in monocytes and B cells of AA mice. In conclusion, upregulated expressions of SP and NK1R may contribute to the pathogenesis of airway allergy. CI - (c) The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. FAU - Han, Peixuan AU - Han P AD - Department of Pathophysiology, Translational Medicine Institute, Shenyang Medical College, Shenyang, Liaoning, China. FAU - Chen, Liping AU - Chen L AD - Department of Respiratory Medicine, The Second Affiliated Hospital of Shenyang Medical College, Shenyang, Liaoning, China. FAU - Chen, Dong AU - Chen D AD - Allergy and Clinical Immunology Research Centre, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. FAU - Yang, Ruiming AU - Yang R AD - Allergy and Clinical Immunology Research Centre, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. FAU - Wang, Wei AU - Wang W AD - Allergy and Clinical Immunology Research Centre, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. FAU - Liu, Jingyu AU - Liu J AD - Allergy and Clinical Immunology Research Centre, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. FAU - He, Shaoheng AU - He S AD - Department of Pathophysiology, Translational Medicine Institute, Shenyang Medical College, Shenyang, Liaoning, China. AD - Allergy and Clinical Immunology Research Centre, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. FAU - Zhang, Huiyun AU - Zhang H AUID- ORCID: 0000-0003-0631-3000 AD - Department of Pathophysiology, Translational Medicine Institute, Shenyang Medical College, Shenyang, Liaoning, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Clin Exp Immunol JT - Clinical and experimental immunology JID - 0057202 RN - 0 (Allergens) RN - 9006-59-1 (Ovalbumin) RN - 0 (Receptors, Neurokinin-1) RN - 33507-63-0 (Substance P) RN - 0 (TACR1 protein, human) SB - IM MH - Animals MH - Mice MH - Allergens MH - *Asthma MH - Monocytes/metabolism MH - Ovalbumin MH - Receptors, Neurokinin-1/genetics/metabolism MH - *Rhinitis, Allergic MH - Substance P/metabolism/pharmacology PMC - PMC9585549 OTO - NOTNLM OT - B cell OT - NK1R OT - allergic asthma OT - allergic rhinitis OT - monocyte OT - substance P EDAT- 2022/08/25 06:00 MHDA- 2022/10/25 06:00 PMCR- 2023/08/24 CRDT- 2022/08/24 14:13 PHST- 2022/01/03 00:00 [received] PHST- 2022/07/21 00:00 [revised] PHST- 2022/08/15 00:00 [accepted] PHST- 2022/08/25 06:00 [pubmed] PHST- 2022/10/25 06:00 [medline] PHST- 2022/08/24 14:13 [entrez] PHST- 2023/08/24 00:00 [pmc-release] AID - 6674696 [pii] AID - uxac074 [pii] AID - 10.1093/cei/uxac074 [doi] PST - ppublish SO - Clin Exp Immunol. 2022 Oct 21;210(1):39-52. doi: 10.1093/cei/uxac074.